QUALITY & COMPLIANCE
Regulatory requirements challenge every system and process.
We ensure compliance and control.
In an industry where innovation moves fast and regulations move faster, maintaining compliance without slowing progress is a constant challenge.
Osprey Life Sciences delivers tailored Quality and Compliance services that help life sciences organizations balance risk and speed.
Staying aligned with regulatory requirements, we combine regulatory expertise with digital tools to streamline audits, validate systems and processes, CAPAs, and quality systems. Our right-sized approach leverages technology, experienced personnel, and proven frameworks to reduce compliance risk and accelerate time-to-market across GxP environments.
- Quality Management System (QMS) Implementation
- Managed Services for Quality & Compliance
- Commissioning, Qualification & Validation (CQV)
- GxP System Support & Documentation
- Compliance, Automation & AI Solutions
- Computer Software Assurance (CSA)
- Periodic Review Programs
- Inspection Readiness
- Regulatory Gap Assessments
- Capabilities Consulting
Customer Success Stories
Discover the impact we’ve made with our life sciences partners
Expanding Digital Foundations for a Growing Cell & Gene Therapy Innovator
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Program Health Check for Global Biopharma Leader: Case Study
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Enhancing Legal IP Correspondence with Centralized SaaS Platform
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Latest Insights
Industry trends, expert perspectives, and innovative solutions
Artificial Intelligence and the Reinvention of Quality Operations – March 2026
Osprey performed an audit focused on documentation, processes, and SQA best practices in order to determine the scale of the issue and potential corrective actions with the expectation that remediation would likely be the next step.
AI in GxP Quality: An Inevitable Future But Proceed with Caution – October 2025
Osprey performed an audit focused on documentation, processes, and SQA best practices in order to determine the scale of the issue and potential corrective actions with the expectation that remediation would likely be the next step.
Global Harmonization and Digital Submissions: A Strategic Guide for Regulatory Professionals
In today’s interconnected pharmaceutical landscape, regulatory professionals face the dual challenge of navigating complex global requirements while embracing digital transformation. The convergence of global harmonization and digital submissions has become a...